Shanghai OPM Biosciences Past Earnings Performance
Past criteria checks 2/6
Shanghai OPM Biosciences has been growing earnings at an average annual rate of 26.3%, while the Biotechs industry saw earnings growing at 5.4% annually. Revenues have been declining at an average rate of 12% per year. Shanghai OPM Biosciences's return on equity is 2.3%, and it has net margins of 19.4%.
Key information
26.3%
Earnings growth rate
3.0%
EPS growth rate
| Biotechs Industry Growth | 11.3% |
| Revenue growth rate | -12.0% |
| Return on equity | 2.3% |
| Net Margin | 19.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Shanghai OPM Biosciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 255 | 49 | 87 | 41 |
| 31 Dec 23 | 243 | 54 | 74 | 43 |
| 30 Sep 23 | 243 | 65 | 71 | 41 |
| 30 Jun 23 | 269 | 90 | 71 | 39 |
| 31 Mar 23 | 290 | 104 | 68 | 37 |
| 31 Dec 22 | 294 | 105 | 65 | 32 |
| 30 Sep 22 | 285 | 97 | 57 | 29 |
| 30 Jun 22 | 277 | 95 | 55 | 23 |
| 31 Mar 22 | 244 | 76 | 52 | 20 |
| 31 Dec 21 | 213 | 60 | 51 | 19 |
| 31 Dec 20 | 125 | 12 | 30 | 21 |
| 31 Dec 19 | 59 | -12 | 18 | 21 |
| 31 Dec 18 | 34 | -42 | 57 | 7 |
Quality Earnings: 688293 has high quality earnings.
Growing Profit Margin: 688293's current net profit margins (19.4%) are lower than last year (36%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688293 has become profitable over the past 5 years, growing earnings by 26.3% per year.
Accelerating Growth: 688293's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688293 had negative earnings growth (-52.6%) over the past year, making it difficult to compare to the Biotechs industry average (-3.2%).
Return on Equity
High ROE: 688293's Return on Equity (2.3%) is considered low.